Home › Funds › TANG CAPITAL MANAGEMENT LLC › DNTH

TANG CAPITAL MANAGEMENT LLC position in DNTH

DIANTHUS THERAPEUTICS INC · Health Care

TANG CAPITAL MANAGEMENT LLC reported holding 264,692 shares of DNTH (DIANTHUS THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$25.8M, representing 1.17% of its reported portfolio and ranking #21 among its reported holdings. TANG CAPITAL MANAGEMENT LLC has disclosed DNTH holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)264.69K sh
Reported value held$25.80M
Portfolio Weight1.17%
First reportedQ3 2023
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How TANG CAPITAL MANAGEMENT LLC's DNTH position evolved

TANG CAPITAL MANAGEMENT LLC first disclosed a stake in DNTH in Q3 2023 at 591,636 shares (US$8.1M). The position peaked in Q2 2026 at 264,692 shares, worth US$25.8M. Across 12 filings, TANG CAPITAL MANAGEMENT LLC increased the stake 0 time(s), trimmed it 2 time(s) and left it unchanged 9 time(s). The most recent filing (Q2 2026) shows 264,692 shares valued at US$25.8M. Notable position changes include a 48% trim in Q1 2024 (shares fell 14% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 591.64K $8.09M New
Q4 2023 504.24K $5.24M Reduce
Q1 2024 264.69K $7.94M Reduce
Q2 2024 264.69K $6.85M Hold
Q3 2024 264.69K $7.25M Hold
Q4 2024 264.69K $5.77M Hold
Q1 2025 264.69K $4.80M Hold
Q2 2025 264.69K $4.93M Hold
Q3 2025 264.69K $10.42M Hold
Q4 2025 264.69K $10.91M Hold
Q1 2026 264.69K $22.21M Hold
Q2 2026 264.69K $25.80M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About DNTH and 13F data

DNTH (DIANTHUS THERAPEUTICS INC) is a Health Care company. 72 other funds we track also report a position in DNTH — the largest reported positions include Fairmount Funds Management LLC (US$247.3M), Avidity Partners Management LP (US$205.1M), Octagon Capital Advisors LP (US$179.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding DNTH

All DNTH fund holders →

FAQ

How long has TANG CAPITAL MANAGEMENT LLC held DNTH?

TANG CAPITAL MANAGEMENT LLC has disclosed DNTH holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is TANG CAPITAL MANAGEMENT LLC's current position in DNTH?

As of Q2 2026, TANG CAPITAL MANAGEMENT LLC holds 264.69K shares of DNTH (DIANTHUS THERAPEUTICS INC), valued at $25.80M, representing 1.17% of its reported portfolio and ranking #21.

Has TANG CAPITAL MANAGEMENT LLC been buying or selling DNTH?

In the latest 13F filing (Q2 2026), TANG CAPITAL MANAGEMENT LLC held unchanged its position in DNTH. The position peaked in Q2 2026 at 264.69K shares.

Which other funds hold DNTH?

Other major institutional holders of DNTH include Fairmount Funds Management LLC, Avidity Partners Management LP, Octagon Capital Advisors LP, among 72 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.